跳至主要内容
临床试验/NCT06421467
NCT06421467尚未招募不适用

Insulin Injection Practices in People With Diabetes in Spain

Fundación para la Investigación del Hospital Clínico de Valencia1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2024年7月最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
400
试验地点
1
主要终点
Type of prandial insulin

研究概览

简要总结

In this era of pharmaceutical and technological advancements, gaining insights into prevalent insulin administration practices under real-life conditions becomes pivotal for healthcare professionals. The investigators aim to explore insulin injection habits through an online survey among a broad, unselected group of participants with type 1 and type 2 diabetes undergoing daily prandial and/or basal insulin treatment. Eligible participants will access and complete the survey at their convenience after providing online informed consent within the study period

详细描述

HYPOTHESIS The study hypothesis posits that there is significant variability in the practices of insulin administration among patients with diabetes using daily insulin injections. This diversity in administration practices may have a notable impact on the overall efficacy of treatment regimens and the successful management of the disease, thereby emphasizing the need for a comprehensive understanding of these practices to enhance patient outcomes and optimize diabetes care.

OBJECTIVES The main objective of the study is to comprehensively assess and characterize the diverse insulin administration practices among individuals with diabetes using injections, focusing on both prandial and basal insulin. By employing an online survey methodology and targeting a broad demographic through a diabetes information platform Canal Diabetes, the investigators aim to gain valuable insights into the variability, challenges, and overall patterns of insulin administration. The findings will contribute to a better understanding of real-world practices, facilitating improvements in patient guidance and optimizing diabetes care strategies.

STUDY DESIGN The study follows a cross-sectional observational design, allowing the investigators to capture a snapshot of the current insulin administration practices via an online questionnaire among the diverse population of diabetes patients using multiple insulin injections.

STUDY PROCEDURE AND SCHEDULE The study, focusing on insulin administration practices among participants with diabetes using multiple insulin injections, will employ a two-month online survey accessible on the designated online platform Canal Diabetes. Recruitment efforts through the diabetes information platform Canal Diabetes will inform eligible participants about the study's voluntary nature, emphasizing response confidentiality. Participants meeting the criteria, will access and complete the online informed consent and survey at their convenience within the designated two-month period. Post-survey, collected data will be securely stored and anonymized for subsequent analysis.

STUDY DURATION The anticipated duration of this study will be 4 months, with subject recruitment set to begin in July 2024 and aiming for the completion of statistical analysis by the 31st of October 2024.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Individuals aged 18 or above
  • Individuals diagnosed with diabetes (type 1 or type 2 diabetes)
  • Individuals receiving multiple daily doses of insulin

排除标准

  • Individuals utilizing continuous subcutaneous insulin infusion
  • Individuals engaging in sensor-augmented pump therapy
  • Individuals using automatic insulin delivery systems

结局指标

主要结局

Type of prandial insulin

时间窗: through study completion, an average of 16 weeks

Type of prandial insulin used

Use of smart pens

时间窗: through study completion, an average of 16 weeks

Use of smart pens (Y/N)

Type of basal insulin

时间窗: through study completion, an average of 16 weeks

Type of basal insulin used

Diabetic ketoacidosis

时间窗: through study completion, an average of 16 weeks

Diabetic ketoacidosis (DKA) in the last year (Y/N)

Time interval before prandial insulin injection

时间窗: through study completion, an average of 16 weeks

If insulin administration occurs before starting the meal: time interval (minutes)

Time interval after prandial insulin injection

时间窗: through study completion, an average of 16 weeks

If insulin administration occurs after the meal: time interval (minutes)

Insulin overdosing

时间窗: through study completion, an average of 16 weeks

Insulin overdosing when correcting abnormal glucose values (Y/N)

Insulin underdosing

时间窗: through study completion, an average of 16 weeks

Insulin overdosing when correcting abnormal glucose values (Y/N)

Change of the insulin needle

时间窗: through study completion, an average of 16 weeks

Frequency in the change of the insulin needle

Hypoglycemic episodes

时间窗: through study completion, an average of 16 weeks

Severe hypoglycemic episodes in the last year (Y/N)

Hyperglycemic episodes

时间窗: through study completion, an average of 16 weeks

Hyperglycemic episodes with medical support in the last year (Y/N)

Self-monitoring of capillary glucose

时间窗: through study completion, an average of 16 weeks

Self-monitoring of capillary blood glucose (SMBG) (Y/N)

Lack of daily glucose monitoring

时间窗: through study completion, an average of 16 weeks

Lack of daily glucose monitoring (Y/N)

Time Below Range (%TbR)

时间窗: through study completion, an average of 16 weeks

If CGM user, CGM parameters from the last 28 days: Time Below Range (%TbR)

Daily dose of prandial insulin

时间窗: through study completion, an average of 16 weeks

Daily dose of prandial insulin (IU/kg)

Number of prandial insulin injections

时间窗: through study completion, an average of 16 weeks

Number of prandial insulin injections per day

Timing of prandial insulin injection

时间窗: through study completion, an average of 16 weeks

Timing of prandial insulin injection: before meals, during meals, after meals, or at some point during the day

Insulin administration site

时间窗: through study completion, an average of 16 weeks

Insulin administration site: abdomen, thigh, arm

Site rotation

时间窗: through study completion, an average of 16 weeks

Injection site rotation: (Yes/No)

Age of diabetes onset

时间窗: through study completion, an average of 16 weeks

Age of diabetes onset (years/months)

Lack of correction based on glucose values

时间窗: through study completion, an average of 16 weeks

Lack of correction based on glucose values (Y/N)

Time Above Range (%TaR)

时间窗: through study completion, an average of 16 weeks

If CGM user, CGM parameters from the last 28 days: Time Above Range (%TaR)

Number of total insulin injections

时间窗: through study completion, an average of 16 weeks

Number of total insulin injections per day

Glucose monitoring in real-time or intermittently scanned

时间窗: through study completion, an average of 16 weeks

Continuous glucose monitoring (CGM) in real-time or intermittently scanned (Y/N)

Coefficient of variation of continuous glucose sensor values (CV)

时间窗: through study completion, an average of 16 weeks

If CGM user, CGM parameters from the last 28 days: coefficient of variation of continuous glucose sensor values (CV)

Number of basal insulin injections

时间窗: through study completion, an average of 16 weeks

Number of basal insulin injections per day

Daily dose of basal insulin

时间窗: through study completion, an average of 16 weeks

Daily dose of basal insulin (IU/kg)

Last HbA1c

时间窗: through study completion, an average of 16 weeks

Last HbA1c value

Date of last HbA1c

时间窗: through study completion, an average of 16 weeks

Date of last HbA1c value

Mean glucose (mg/dL)

时间窗: through study completion, an average of 16 weeks

If CGM user, CGM parameters from the last 28 days: mean glucose (mg/dL)

Time in Range (%TIR)

时间窗: through study completion, an average of 16 weeks

If CGM user, CGM parameters from the last 28 days: Time in Range (%TIR)

次要结局

未报告次要终点

研究者

发起方
Fundación para la Investigación del Hospital Clínico de Valencia
申办方类型
Other
责任方
Principal Investigator
主要研究者

Francisco Javier Ampudia Blasco

Principal Investigator

Fundación para la Investigación del Hospital Clínico de Valencia

研究点 (1)

Loading locations...

相似试验